Stockholm - Delayed Quote SEK

PEPTONIC Medical AB (PMED.ST)

0.0038
+0.0004
+(11.76%)
At close: May 13 at 4:36:35 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
26,891
26,891
37,118
43,634
31,643
Cost of Revenue
11,731
11,731
20,823
20,239
12,573
Gross Profit
15,160
15,160
16,295
23,395
19,070
Operating Expense
55,762
55,762
57,481
57,001
92,787
Operating Income
-40,602
-40,602
-41,186
-33,606
-73,717
Net Non Operating Interest Income Expense
-1,380
-1,380
-1,404
-3,251
30
Pretax Income
-60,028
-60,028
-42,589
-36,857
-73,688
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-60,028
-60,028
-42,589
-36,857
-73,688
Diluted NI Available to Com Stockholders
-60,028
-60,028
-42,589
-36,857
-73,688
Basic EPS
-0.01
-0.02
-0.04
-0.07
-0.18
Diluted EPS
-0.01
-0.02
-0.04
-0.07
-0.18
Basic Average Shares
5,755,463.0720
5,759,303.0140
1,989,614.6610
514,360.4290
406,074.0270
Diluted Average Shares
5,755,463.0720
5,759,303.0140
1,989,614.6610
514,360.4290
406,074.0270
Total Operating Income as Reported
--
--
-41,186
-33,606
-73,718
Total Expenses
67,493
67,493
78,304
77,240
105,360
Net Income from Continuing & Discontinued Operation
-60,028
-60,028
-42,589
-36,857
-73,688
Normalized Income
-41,982
-41,982
-42,589
-36,857
-73,688
Interest Income
32
32
919
2,313
102
Interest Expense
1,412
1,412
2,323
5,564
72
Net Interest Income
-1,380
-1,380
-1,404
-3,251
30
EBIT
-58,616
-58,616
-40,266
-31,293
-73,616
EBITDA
-51,930
-51,930
-34,000
-27,802
-46,561
Reconciled Cost of Revenue
11,731
11,731
20,823
20,239
12,573
Reconciled Depreciation
6,686
6,686
6,266
3,491
27,055
Net Income from Continuing Operation Net Minority Interest
-60,028
-60,028
-42,589
-36,857
-73,688
Total Unusual Items Excluding Goodwill
-18,046
-18,046
0
--
--
Total Unusual Items
-18,046
-18,046
0
--
--
Normalized EBITDA
-33,884
-33,884
-34,000
-27,802
-46,561
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/2/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VIVE.ST Vivesto AB
0.2280
-1.08%
 
NANEXA.ST Nanexa AB (publ)
1.9400
-8.27%
 
AKAN Akanda Corp.
1.2200
-1.61%
 
FLGC Flora Growth Corp.
0.7277
-2.97%
 
AMRX Amneal Pharmaceuticals, Inc.
7.50
-1.32%
 
YCBD cbdMD, Inc.
1.0100
+6.32%
 
SBFM Sunshine Biopharma, Inc.
1.3600
+0.74%
 
UPC Universe Pharmaceuticals INC
5.12
+15.58%
 
PRFX PainReform Ltd.
1.9200
+1.05%
 
PTPI Petros Pharmaceuticals, Inc.
0.1268
+6.11%